McErlean E - Search Results

1

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE; ACCELERATE Investigators. Lincoff AM, et al. Among authors: mcerlean e. N Engl J Med. 2017 May 18;376(20):1933-1942. doi: 10.1056/NEJMoa1609581. N Engl J Med. 2017. PMID: 28514624 Free article. Clinical Trial.

2

Ability of troponins to predict adverse outcomes in patients with renal insufficiency and suspected acute coronary syndromes: a case-matched study.

Van Lente F, McErlean ES, DeLuca SA, Peacock WF, Rao JS, Nissen SE. Van Lente F, et al. Among authors: mcerlean es. J Am Coll Cardiol. 1999 Feb;33(2):471-8. doi: 10.1016/s0735-1097(98)00592-0. J Am Coll Cardiol. 1999. PMID: 9973028 Free article.

3

Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes.

Peacock WF IV, Emerman CL, McErlean ES, Deluca SA, van Lente F, Rao JS, Nissen SE. Peacock WF IV, et al. Among authors: mcerlean es. Ann Emerg Med. 2000 Mar;35(3):213-20. Ann Emerg Med. 2000. PMID: 10692186

4

The vulnerable coronary plaque.

Schoenhagen P, McErlean ES, Nissen SE. Schoenhagen P, et al. Among authors: mcerlean es. J Cardiovasc Nurs. 2000 Oct;15(1):1-12. doi: 10.1097/00005082-200010000-00002. J Cardiovasc Nurs. 2000. PMID: 11061217 Review.

5

Using troponin T to diagnose acute coronary syndromes.

McErlean E, Van Lente CF, Nissen SE. McErlean E, et al. Cleve Clin J Med. 2000 Nov;67(11):843-9. doi: 10.3949/ccjm.67.11.843. Cleve Clin J Med. 2000. PMID: 11104335 Free article.

6

Normal CK, elevated MB predicts complications in acute coronary syndromes.

Peacock WF, Emerman CL, McErlean ES, DeLuca SA, VanLente F, Lowrie M, Rao JS, Nissen SE. Peacock WF, et al. Among authors: mcerlean es. J Emerg Med. 2001 May;20(4):385-90. doi: 10.1016/s0736-4679(01)00317-1. J Emerg Med. 2001. PMID: 11348820

7

Troponin T in elders with suspected acute coronary syndromes.

Noeller TP, Meldon SW, Peacock WF, Emerman CL, McErlean ES, Vanlente F, Nissen SE. Noeller TP, et al. Among authors: mcerlean es. Am J Emerg Med. 2003 Jul;21(4):293-7. doi: 10.1016/s0735-6757(03)00081-0. Am J Emerg Med. 2003. PMID: 12898485

8

Prognostic value of myeloperoxidase in patients with chest pain.

Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M, Pepoy ML, McErlean ES, Topol EJ, Nissen SE, Hazen SL. Brennan ML, et al. Among authors: mcerlean es. N Engl J Med. 2003 Oct 23;349(17):1595-604. doi: 10.1056/NEJMoa035003. N Engl J Med. 2003. PMID: 14573731 Free article.

9

Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.

Nissen SE, Nicholls SJ, Wolski K, Howey DC, McErlean E, Wang MD, Gomez EV, Russo JM. Nissen SE, et al. Among authors: mcerlean e. JAMA. 2007 Mar 28;297(12):1362-73. doi: 10.1001/jama.297.12.1362. Epub 2007 Mar 25. JAMA. 2007. PMID: 17384435 Clinical Trial.

10

Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.

Nicholls SJ, Brewer HB, Kastelein JJ, Krueger KA, Wang MD, Shao M, Hu B, McErlean E, Nissen SE. Nicholls SJ, et al. Among authors: mcerlean e. JAMA. 2011 Nov 16;306(19):2099-109. doi: 10.1001/jama.2011.1649. JAMA. 2011. PMID: 22089718 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page